The study team found it was possible to give an individual increased targeted dose of radiotherapy.
The radiotherapy dose for each person was to be higher than the
standard dose 
of radiotherapy used for non small cell lung cancer.
Of the 37 people who took part:
- 2 people had standard radiotherapy instead of the targeted radiotherapy, this was due to the size of their cancer
- 14 people were able to have the highest dose of radiotherapy
- 1 person didn’t complete their radiotherapy because their cancer continued to grow
After an average follow up of just over a year, 20 people were still alive.
The team looked at side effects that happened during the radiotherapy and for 4 months afterwards (short term side effects). These included:
- a cough
- difficulty swallowing
- shortness of breath
- inflammation of the food pipe
- skin problems at the treatment area
They also looked at side effects that continued on 4 months after radiotherapy (long term side effects). These included:
- a cough
- difficulty swallowing
- shortness of breath
The team concluded an individual targeted dose of radiotherapy to treat non small cell lung cancer was possible. And the side effects weren’t too bad. A trial called ADSCaN is comparing different ways of giving an increased dose of radiotherapy to the standard ways of giving radiotherapy for non small cell lung cancer.
We have based this summary on information from the research team. The information they sent us has been reviewed by independent specialists (
peer reviewed 
) but may not have been published in a medical journal. The figures we quote above were provided by the research team. We have not analysed the data ourselves.